Interview with Dr. Marijin Lijffijt who is a neuropsychopharmacologist by training and now works as a consultant for various biotech and pharma start-ups.  We talk about his transition from being a PI in academia to the start-up world, some of the projects related to EEG biomarkers that he is currently working on, how relatively little the world knows about mental health disorders, paths to finding out more about these disorders (which may lead to better treatments and identification), the future of neurotech, and more! Recently he has worked with Sage Therapeutics and Sama Therapeutics.  Recorded January 2, 2024. Host: Robert Murcko Key Moments:  0:00 Intro 5:50 Transition from Academia Into Startups 13:00 Dr. Lijffijt’s projects with Sama Therapeutics 24:18 Brief discussion about AI and machine learning and how they are revolutionizing the field of biotech 26:09 Predictions for the future of neurotech 33:51 Closing remarks and Dr. Lijffijt’s contact information Links Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe Dr. Marijin Lijffijt’s LinkedIn: https://www.linkedin.com/in/cns-treatment-innovation/ Sama Therapeutics: https://sama.ac/